Skip to main content
. 2019 Aug 22;14:151. doi: 10.1186/s13014-019-1350-9

Table 1.

Patient characteristics and treatment details after propensity score matching

Characteristics ART+IMRT
(n = 50)
IMRT
(n = 50)
P
Age (years) 54 (16~72) 55 (22~73) 0.865
Gender 0.500
 Male 33 (66%) 34 (68%)
 Female 17 (34%) 16 (32%)
History of smoking 0.500
 Yes 22 (44%) 23 (46%)
 No 28 (56%) 27 (54%)
History of drinking 0.795
 Yes 8 (16%) 10 (20%)
 No 42 (84%) 40 (80%)
Family history 0.795
 Yes 10 (20%) 8 (16%)
 No 40 (80%) 42 (84%)
T stage 1
 T1 1 (2%) 1 (2%)
 T2 29 (58%) 29 (58%)
 T3 14 (28%) 14 (28%)
 T4 6 (12%) 6 (12%)
N stage 1
 N0 7 (14%) 7 (14%)
 N1 11 (22%) 11 (22%)
 N2 27 (54%) 27 (54%)
 N3 5 (10%) 5 (10%)
Clinical stage 1
 II 3 (6%) 3 (6%)
 III 40 (80%) 40 (80%)
 IV 7 (14%) 7 (14%)
 CCT 50 (100%) 50 (100%) 1

Abbreviations: IMRT Intensity-modulated radiotherapy, ART adaptive radiotherapy, CCT concurrent chemotherapy